BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Prognosis
72 results:

  • 1. prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature.
    Wang Y; Wang DY; Bu KN; Gao JD; Zhang BL
    Sci Rep; 2024 Feb; 14(1):2859. PubMed ID: 38310106
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. breast cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status.
    Xu S; Murtagh S; Han Y; Wan F; Toriola AT
    JAMA Netw Open; 2024 Jan; 7(1):e2353331. PubMed ID: 38277147
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer.
    Li X; Zhang Y; Zhu C; Xu W; Hu X; Martínez DAS; Romero JLA; Yan M; Dai Y; Wang H
    BMC Womens Health; 2024 Jan; 24(1):38. PubMed ID: 38218823
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
    Bae SJ; Kim HJ; Kim HA; Ryu JM; Park S; Lee EG; Im SA; Jung Y; Park MH; Park KH; Kang SH; Park E; Kim SY; Lee MH; Kim LS; Lee A; Noh WC; Gwark S; Kim S; Jeong J
    Int J Surg; 2024 Feb; 110(2):934-942. PubMed ID: 38000057
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Opioid prescriptions at the point of surgery, bone metastasis, or death among patients with breast cancer in Japanese acute care hospitals: a claims-based, retrospective, longitudinal study.
    Yoshida M; Iwasaki K; Miyashita M; Saeki T; Morioka Y; Hiroi S; Shimizu E
    Support Care Cancer; 2023 Jun; 31(6):369. PubMed ID: 37266722
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer.
    Hu J; Lang R; Zhao W; Jia Y; Tong Z; Shi Y
    Breast Cancer Res Treat; 2023 Jul; 200(1):23-36. PubMed ID: 37160814
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The aldh2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for prognosis in breast cancer.
    Han Y; Fu Y; Shi Q; Liu H; Sun H; Niu C; Fu L
    Clin Breast Cancer; 2023 Apr; 23(3):e140-e150. PubMed ID: 36639264
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MicroRNA-217 aggravates breast cancer through activation of NF1-mediated HSF1/ATG7 axis and c-Jun/ATF3/MMP13 axis.
    Li W; Yang C; Li J; Li X; Zhou P
    Hum Cell; 2023 Jan; 36(1):377-392. PubMed ID: 36357766
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Paradoxes of breast cancer incidence and mortality in two corners of Europe.
    Roginski M; Sifaki-Pistolla D; Stomby A; Velivasaki G; Faresjö T; Lionis C; Faresjö Å
    BMC Cancer; 2022 Nov; 22(1):1123. PubMed ID: 36319987
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis.
    Zhang D; Liu J; Zheng M; Meng C; Liao J
    World J Surg Oncol; 2022 Oct; 20(1):351. PubMed ID: 36309698
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Exploration of the breast ductal carcinoma in situ signature and its prognostic implications.
    Zhang J; Lin H; Hou L; Xiao H; Gong X; Guo X; Cao X; Liu Z
    Cancer Med; 2023 Feb; 12(3):3758-3772. PubMed ID: 35880695
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer.
    Gong C; Cheng Z; Yang Y; Shen J; Zhu Y; Ling L; Lin W; Yu Z; Li Z; Tan W; Zheng C; Zheng W; Zhong J; Zhang X; Zeng Y; Liu Q; Huang RS; Komorowski AL; Yang ES; Bertucci F; Ricci F; Orlandi A; Franceschini G; Takabe K; Klimberg S; Ishii N; Toss A; Tan MP; Cherian MA; Song E
    Sci China Life Sci; 2022 Nov; 65(11):2205-2217. PubMed ID: 35579777
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Relationship between the changes of positivity rate of HER2 expression and the diameter of invasive lesions in early breast cancer and its clinical significance.
    Han D; Shen R; Yue M; Zhao M; Yu Y; Yao J; Liu Y
    Pathol Res Pract; 2022 May; 233():153877. PubMed ID: 35398619
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Randomized Trial of a Palliative Care Intervention to Improve End-of-Life Care Discussions in Patients With Metastatic breast cancer.
    Greer JA; Moy B; El-Jawahri A; Jackson VA; Kamdar M; Jacobsen J; Lindvall C; Shin JA; Rinaldi S; Carlson HA; Sousa A; Gallagher ER; Li Z; Moran S; Ruddy M; Anand MV; Carp JE; Temel JS
    J Natl Compr Canc Netw; 2022 Feb; 20(2):136-143. PubMed ID: 35130492
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.
    Wang Z; Yang L; Wu P; Li X; Tang Y; Ou X; Zhang Y; Xiao X; Wang J; Tang H
    Mol Cancer; 2022 Jan; 21(1):29. PubMed ID: 35073911
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Screening a prognosis-Related Target Gene in Patients with HER-2-Positive breast cancer by Bioinformatics Analysis.
    Wang S; Deng J; Gao X; Lv H; Quan Y
    Med Princ Pract; 2021; 30(4):376-384. PubMed ID: 33823519
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Effect of Metformin on Survival Outcomes of Non-Metastatic breast cancer Patients with Type 2 Diabetes.
    Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
    Tanaka Y; Ohno T; Kadonaga T; Kidokoro Y; Wakahara M; Nosaka K; Sakabe T; Suzuki Y; Nakamura H; Umekita Y
    Breast Cancer; 2021 Jul; 28(4):822-828. PubMed ID: 33481184
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
    Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
    Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mouse Mammary Tumor Virus (MMTV)-Like
    de Sousa Pereira N; Akelinghton Freire Vitiello G; Karina Banin-Hirata B; Scantamburlo Alves Fernandes G; José Sparça Salles M; Karine Amarante M; Angelica Ehara Watanabe M
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33352945
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 4.